Research and Markets has announced the addition of the "Global Big Pharma Partnering Terms and Agreements 2010-2016: Deal trends, players and financials" report to their offering.

Global Big Pharma Partnering Terms and Agreements 2010 to 2016 report provides a detailed understanding and analysis of how and why companies enter Big Pharma partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.

The report takes the reader through a comprehensive review Big Pharma deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Big Pharma partnering deals.

The report presents financial deal term values for Big Pharma deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

Key benefits

  • In-depth understanding of Big Pharma deal trends since 2010
  • Access to headline, upfront, milestone and royalty data
  • Analysis of the structure of Big Pharma agreements with real life case studies
  • Detailed access to actual Big Pharma contracts entered into by leading biopharma companies
  • Identify most active Big Pharma dealmakers since 2010
  • Insight into terms included in a Big Pharma partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

In Global Big Pharma Partnering 2010-2016: Deal trends, players, financials and forecasts, the available deals are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target
  • Technology type

Key Topics Covered:

Executive Summary

Chapter 1 Introduction

Chapter 2 Trends in Big Pharma dealmaking

Chapter 3 Leading Big Pharma deals

Chapter 4 Most active Big Pharma dealmakers

Chapter 5 Big Pharma contracts dealmaking directory

Chapter 6 Big Pharma dealmaking by technology type

Chapter 7 Partnering resource center

For more information about this report visit http://www.researchandmarkets.com/research/5krd77/global_big_pharma